c-Jun, a crucial molecule in metastasis of breast cancer and potential target for biotherapy

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1207-1212

  Zhang, Yan ^a,b   Pu, Xiaoyun ^b   Shi, Ming ^a   Chen, Liyong ^a   Qian, Lu ^a   Song, Yuhua ^a,c   Yuan, Guogang ^a   Zhang, Hao ^a   Yu, Ming ^a   Hu, Meiru ^a   Shen, Beifen ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Beijing 307 Hospital   (China)

Author keywords

Animal model; AP 1; c Jun; Metastasis; Tumorigenesis

Indexed keywords

PROTEIN C JUN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BREAST TUMOR; CANCER INVASION; CELL MOTION; DISEASE MODEL; FEMALE; GENETICS; HUMAN; LIVER TUMOR; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-JUN; TRANSPLANTATION, HETEROLOGOUS;

EID: 38449089726     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1207     Document Type: Article

References (28)

1. Angel P and Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-157, 1991. (Pubitemid 121007534)
2. Behrens A, Sibilia M and Wagner EF: Amino-terminal phosphory-lation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21: 326-329, 1999. (Pubitemid 29124945)
3. Curran T and Franza BR Jr: Fos and Jun: the AP-1 connection. Cell 55: 395-397, 1988. (Pubitemid 18261431)
4. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739, 1987. (Pubitemid 18094763)
5. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ: cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18: 6063-6070, 1999. (Pubitemid 29535018)
6. Malliri A, Symons M, Hennigan RF, Hurlstone AF, Lamb RF, Wheeler T and Ozanne BW: The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 143: 1087-1099, 1998. (Pubitemid 28547406)
7. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE and Yarden Y: ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15: 254-264, 1996. (Pubitemid 26029205)
8. Riese DJ, van Raaij TM, Plowman GD, Andrews GC and Stern DF: The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 15: 5770-5776, 1995.
9. Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D and Tang C: The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Res Treat 38: 57-66, 1996. (Pubitemid 26031066)
10. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289, 2004. (Pubitemid 38264873)
11. Belguise K, Kersual N, Galtier F and Chalbos D: FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24: 1434-1444, 2005. (Pubitemid 40343123)
12. Du Manoir JM, Francia G, Man S, Mossoba M, Medin JA, Viloria-Petit A, Hicklin DJ, Emmenegger U and Kerbel RS: Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. Clin Cancer Res 12: 904-916, 2006. (Pubitemid 43259873)
13. Clarke R: Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat 39: 69-86, 1996.
14. Abate C and Curran T: Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol 1: 19-26, 1990.
15. Zhang L, Bewick M and Lafrenie RM: EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Lab Invest 82: 71-78, 2002. (Pubitemid 34072647)
16. Uherek C, Tonn T, Uherek B, Becker S, Schnierle B, Klingemann HG and Wels W: Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood 100: 1265-1273, 2002. (Pubitemid 34864281)
17. Denhardt DT: Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318: 729-747, 1996.
18. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M and Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994. (Pubitemid 24106383)
19. Smeal T, Binetruy B, Mercola DA, Birrer M and Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-496, 1991. (Pubitemid 21896867)
20. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG and Hauser CA: Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem 271: 7992-7998, 1996. (Pubitemid 26108618)
21. Menard S, Tagliabue E, Campiglio M and Pupa SM: Role of HER2 gene overexpression in breast carcinoma. J Cell Physiol 182: 150-162, 2000. (Pubitemid 30022667)
22. Milde-Langosch K, Bamberger AM, Methner C, Rieck G and Loning T: Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members. Int J Cancer 87: 468-472, 2000. (Pubitemid 30639803)
23. Milde-Langosch K, Roder H, Andritzky B, Aslan B, Hemminger G, Brinkmann A, Bamberger CM, Loning T and Bamberger AM: The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 86: 139-152, 2004. (Pubitemid 38988017)
24. Rinehart-Kim J, Johnston M, Birrer M and Bos T: Alterations in the gene expression profile of MCF-7 breast tumor cells in response to c-Jun. Int J Cancer 88: 180-190, 2000.
25. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612, 2004. (Pubitemid 39552073)
26. Guidi AJ, Fischer L, Harris JR and Schnitt SJ: Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86: 614-619, 1994. (Pubitemid 24143171)
27. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991. (Pubitemid 121001209)
28. McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, Turnage R, McDonald JC, Abreo F and Li BD: A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Ann Surg 242: 584-590, 2005.